Purpose
For transient expression of Emicizumab sequence (CAS# 1610943-06-0, KEGG# D10821), IgG4 bispecific antibody targeting FIX(a) & FX(a). Must be co-expressed with anti-FIX(a) and anti-FX(a) Emi HC's.
Insert
Emicizumab light chain
Available Since
March 29, 2019
Availability
Academic Institutions and Nonprofits only